NDC 57664-327

Ticlopidine Hydrochloride

Ticlopidine Hydrochloride

Ticlopidine Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Caraco Pharmaceutical Laboratories, Ltd.. The primary component is Ticlopidine Hydrochloride.

• Product ID: 57664-327_aa3b8a6e-c60c-47e3-8ccf-54d73c7e42aa
• NDC: 57664-327
• Product Type: Human Prescription Drug
• Proprietary Name: Ticlopidine Hydrochloride
• Generic Name: Ticlopidine Hydrochloride
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2002-09-26
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075526
• Labeler Name: Caraco Pharmaceutical Laboratories, Ltd.
• Substance Name: TICLOPIDINE HYDROCHLORIDE
• Active Ingredient Strength: 250 mg/1
• Pharm Classes: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 57664-327-88

100 TABLET, FILM COATED in 1 BOTTLE (57664-327-88)

• Marketing Start Date: 2002-09-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 57664-327-83 [57664032783]

Ticlopidine Hydrochloride TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA075526
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2002-09-26
• Marketing End Date: 2016-05-31

NDC 57664-327-86 [57664032786]

Ticlopidine Hydrochloride TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA075526
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2002-09-26
• Marketing End Date: 2016-05-31

NDC 57664-327-88 [57664032788]

Ticlopidine Hydrochloride TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA075526
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2002-09-26
• Marketing End Date: 2016-05-31

NDC 57664-327-06 [57664032706]

Ticlopidine Hydrochloride TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA075526
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2002-09-26
• Marketing End Date: 2016-05-31

NDC 57664-327-13 [57664032713]

Ticlopidine Hydrochloride TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA075526
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2002-09-26
• Marketing End Date: 2016-05-31

Drug Details

Active Ingredients

Ingredient	Strength
TICLOPIDINE HYDROCHLORIDE	250 mg/1

OpenFDA Data

• SPL SET ID: aa3b8a6e-c60c-47e3-8ccf-54d73c7e42aa
• Manufacturer:
  • Caraco Pharmaceutical Laboratories, Ltd.
• UNII:
  • A1L4914FMF
• RxNorm Concept Unique ID - RxCUI:
  • 313406
• UPC Code:
  • 0357664327869

Pharmacological Class

• Decreased Platelet Aggregation [PE]
• Platelet Aggregation Inhibitor [EPC]

Medicade Reported Pricing

57664032786 TICLOPIDINE 250 MG TABLET

Pricing Unit: EA | Drug Type:

57664032783 TICLOPIDINE 250 MG TABLET

Pricing Unit: EA | Drug Type:

57664032713 TICLOPIDINE 250 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Ticlopidine Hydrochloride" or generic name "Ticlopidine Hydrochloride"

NDC	Brand Name	Generic Name
0185-0115	Ticlopidine Hydrochloride	Ticlopidine Hydrochloride
57664-327	Ticlopidine Hydrochloride	Ticlopidine Hydrochloride
68151-0079	Ticlopidine Hydrochloride	Ticlopidine Hydrochloride